Literature DB >> 12722501

Water apparent diffusion coefficient and T2 changes in the acute stage of maple syrup urine disease: evidence of intramyelinic and vasogenic-interstitial edema.

Andrea Righini1, Luca A Ramenghi, Rossella Parini, Fabio Triulzi, Fabio Mosca.   

Abstract

BACKGROUND: The acute phase of the neonatal classical form of maple syrup urine disease (MSUD) is usually associated with generalized brain edema. METHODS AND
RESULTS: The authors present the case of a newborn infant in the acute stage of the classical form of MSUD in whom a remarkable decrease in the water apparent diffusion coefficient (ADC) in advanced myelinating white matter areas was associated with an increase in the T2 signal. This diffusion magnetic resonance imaging (MRI) pattern appears to be compatible with a rare kind of cytotoxic edema, the so-called intramyelinic edema. At the same time, an increase in the ADC was seen in unmyelinated areas together with an increase in the T2 signal, a sign of a coexistent vasogenic-interstitial edema.
CONCLUSIONS: ADC measurements in MSUD provide more specific information than conventional MRI about the pathophysiology of white matter changes.

Entities:  

Mesh:

Year:  2003        PMID: 12722501

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  20 in total

1.  Brain apparent diffusion coefficient decrease during correction of severe hypernatremic dehydration.

Authors:  Andrea Righini; Luca Ramenghi; Salvatore Zirpoli; Fabio Mosca; Fabio Triulzi
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

Review 2.  Paediatric neuroimaging.

Authors:  Fabio Triulzi
Journal:  Neurol Sci       Date:  2008-10       Impact factor: 3.307

3.  Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis.

Authors:  Rukiye Kilicarslan; Alpay Alkan; Demet Demirkol; Huseyin Toprak; Rasul Sharifov
Journal:  Jpn J Radiol       Date:  2012-04-03       Impact factor: 2.374

Review 4.  Patterns of damage in the mature neonatal brain.

Authors:  Fabio Triulzi; Cecilia Parazzini; Andrea Righini
Journal:  Pediatr Radiol       Date:  2006-05-18

5.  MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.

Authors:  Ailan Cheng; Lianshu Han; Yun Feng; Huimin Li; Rong Yao; Dengbin Wang; Biao Jin
Journal:  Diagn Interv Radiol       Date:  2017 Sep-Oct       Impact factor: 2.630

6.  Cerebral Oedema, Blood-Brain Barrier Breakdown and the Decrease in Na(+),K(+)-ATPase Activity in the Cerebral Cortex and Hippocampus are Prevented by Dexamethasone in an Animal Model of Maple Syrup Urine Disease.

Authors:  Luciana Rosa; Leticia S Galant; Dhébora M Dall'Igna; Janaina Kolling; Cassiana Siebert; Patrícia F Schuck; Gustavo C Ferreira; Angela T S Wyse; Felipe Dal-Pizzol; Giselli Scaini; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2015-07-02       Impact factor: 5.590

Review 7.  Cytoskeleton as a potential target in the neuropathology of maple syrup urine disease: insight from animal studies.

Authors:  R Pessoa-Pureur; M Wajner
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

8.  Biochemical correlates of neuropsychiatric illness in maple syrup urine disease.

Authors:  Emilie R Muelly; Gregory J Moore; Scott C Bunce; Julie Mack; Don C Bigler; D Holmes Morton; Kevin A Strauss
Journal:  J Clin Invest       Date:  2013-03-08       Impact factor: 14.808

9.  Maple syrup urine disease encephalopathy: a follow-up study in the acute stage using diffusion-weighted MRI.

Authors:  Jong Su Ha; Taik-Kun Kim; Baik-Lin Eun; Hee Sun Lee; Ki Yeol Lee; Hae Young Seol; Sang Hoon Cha
Journal:  Pediatr Radiol       Date:  2003-09-18

10.  Structural white matter changes in adolescents and young adults with maple syrup urine disease.

Authors:  D Klee; E Thimm; H J Wittsack; D Schubert; R Primke; G Pentang; J Schaper; U Mödder; A Antoch; U Wendel; M Cohnen
Journal:  J Inherit Metab Dis       Date:  2013-01-25       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.